What are the neurotoxic effects associated with the use of bevacizumab in cancer patients?
Fuente:
Zenodo
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Recurso digital |
| Pubblicazione: |
Zenodo
2025
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866901250653552640 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Bevacizumab is associated with neurotoxic effects, predominantly Posterior Reversible Encephalopathy Syndrome (PRES), which usually resolves after discontinuation but may lead to ongoing sequelae. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17689280 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What are the neurotoxic effects associated with the use of bevacizumab in cancer patients? Tripdatabase neurotoxic effects associated use bevacizumab cancer patients Bevacizumab is associated with neurotoxic effects, predominantly Posterior Reversible Encephalopathy Syndrome (PRES), which usually resolves after discontinuation but may lead to ongoing sequelae. |
| title | What are the neurotoxic effects associated with the use of bevacizumab in cancer patients? |
| topic | neurotoxic effects associated use bevacizumab cancer patients |
| url | https://doi.org/10.5281/zenodo.17689280 |